Pharvaris (PHVS) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

PHVS Pharvaris

Watchlist

19.170
+0.150+0.79%

Close Dec 31 16:00 ET

18.120
-1.050-5.48%

Pre 04:41 ET

1.04BMarket Cap-7.12P/E (TTM)

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Analysts Offer Insights on Healthcare Companies: Pharvaris (PHVS), Ascendis Pharma (ASND) and BioNTech SE (BNTX)
TipRanks56minutes ago · Ratings
JMP Securities Maintains Pharvaris(PHVS.US) With Buy Rating, Cuts Target Price to $46
Moomoo NewsDec 5, 2024 12:31 ET · Ratings
Pharvaris Price Target Lowered to $46 From $50 at JMP Securities
TipRanksDec 5, 2024 06:47 ET
We're Not Very Worried About Pharvaris' (NASDAQ:PHVS) Cash Burn Rate
Simply Wall StDec 2, 2024 07:34 ET
Pharvaris's Strategic Progress in HAE Pipeline Drives Buy Rating and $30 Price Target
TipRanksNov 19, 2024 01:55 ET · Ratings
Oppenheimer Maintains Pharvaris(PHVS.US) With Buy Rating, Maintains Target Price $42
Moomoo NewsNov 14, 2024 08:31 ET · Ratings

Comments

70617300

Aug 15, 2024 08:18

Oppenheimer analyst Jeff Jones maintains $Pharvaris (PHVS.US)$ with a buy rating, and maintains the target price at $38.
According to TipRanks data, the analyst has a success rate of 36.7% and a total average return of 6.4% over the past year.

Alvinnnnnnngenius

Dec 6, 2023 05:50

$Pharvaris (PHVS.US)$ Pharvaris Announces Positive Top-line Phase 2 Data from the CHAPTER-1 Study of Deucrictibant for the Prophylactic Treatment of HAE Attacks

BioPharm Insight US

Dec 12, 2022 10:20

Columns Weekly FDA Drug Pipeline Calendar (Dec 12 - Dec 17)

Hello mooers, welcome to another week of the FDA calendar. Here are what happened last week and what's coming up this week.
$Amgen (AMGN.US)$ Inc. is in advanced talks to buy drug company $Horizon Therapeutics (HZNP.US)$, according to people familiar with the matter, in a takeover likely to be valued at well over $20 billion and mark the largest healthcare merger of the year.
$ROCHESTER RESOURCES LTD (RCTFF.US)$Holding AG presented new data from a ...

PepePumper

Dec 9, 2022 11:28

$HTG Molecular Diagnostics (HTGM.US)$ Everyone seems to have slept on this one $Baudax Bio (BXRX.US)$ $Ambrx Biopharma (AMAM.US)$ $Pharvaris (PHVS.US)$

ilovemoney29

Dec 9, 2022 09:59

$Pharvaris (PHVS.US)$ back in aug because of fda halt this dropped from 18 to under 10. now that it has succeeded, possible increase back?

Heat List

Overall

No Data